An Ex Vivo Technique to Induce Neuronal Death via Oligodendrocyte-Specific CD8+ T Cells
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:50 min • July 8th, 2025
Oligodendrocytes, which are specialized cells of the central nervous system, form myelin sheaths around neurons. Myelin insulates the axon and facilitates the rapid conduction of electrical impulses. Demyelination — the destruction of myelin — leads to neuronal death.
To study neuronal death, take a transgenic mouse brain fixed on a vibratome plate. Immerse the brain in an ice-cold buffer, preserving the structural integrity while sectioning.
Using a vibratome, obtain thin coronal sections. Transfer the sections to a culture well containing an appropriate medium.
The oligodendrocytes in the transgenic mouse brain express a foreign antigen, which is displayed on the cell surface via the major histocompatibility complex.
Add a solution of activated CD8+ T cells — specific for the foreign antigen — onto the sections and incubate.
The T cell receptor binds to its antigen displayed on the oligodendrocyte. The co-stimulatory molecule binds to its ligand. The binding initiates a signaling cascade inside the T cell, causing the release of perforin and granzymes — cytotoxic mediators.
Perforin creates pores in the oligodendrocyte membrane, through which granzymes enter the cytoplasm. Further, Fas ligands on the T cells bind to their receptors on the oligodendrocyte surface. Granzymes, along with the Fas ligand binding, induce the apoptotic pathway in oligodendrocytes, leading to demyelination and neuronal death.
Post-incubation, the treated brain sections are ready for the assessment of cell death.
For this experiment, have 8- to 10-week-old transgenic ODC-OVA mice and age- and sex-matched C57Bl/6 controls. As usual, house the mice in a pathogen-free environment with free access to food and water. After anesthetizing a mouse, use a back paw pinch to assess the level of anesthesia, and then immediately euthanize it.
Now position a mouse ventrally, and disinfect the scalp, and decapitate it. Next, quickly, cut the scalp, open the cranium, and scoop out the brain. Fix the brain in place using glue, and transfer it to a vibratome plate, then, fill the plate with ice-cold placedine physiological saline. Once prepared, cut 300-micron slices. Transfer the slices to individual wells of a 12- or 24-well plate filled with aCSF. Then carefully add 1/2 a million OT-I T cells to each slice.
Half a million activated cells per slice provides good cell-cell interaction. Once the cells start migrating into the slice, at the same time, the amount of cells is not too high to induce an overreaction. So single-cell counting is feasible.
After loading all the wells, incubate the co-culture for up to eight hours. After the incubation, harvest the slices, and embed them in OCT compound, then, freeze the embedded slices in liquid nitrogen and store them at negative 20 Celsius for further histological studies.
Overview
This study investigates the role of oligodendrocytes in neuronal death through the mechanism of demyelination. Using transgenic mouse models, the interaction between activated CD8+ T cells and oligodendrocytes is explored to understand the apoptotic pathways involved.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Immunology
Background
- Oligodendrocytes form myelin sheaths that insulate neuronal axons.
- Demyelination can lead to neuronal death and is a critical area of study in neurodegenerative diseases.
- Understanding the mechanisms of oligodendrocyte apoptosis is essential for developing therapeutic strategies.
- Transgenic mouse models allow for the study of specific cellular interactions in a controlled environment.
Purpose of Study
- To elucidate the mechanisms by which activated CD8+ T cells induce apoptosis in oligodendrocytes.
- To assess the impact of T cell interactions on myelin integrity and neuronal survival.
- To provide insights into the cellular pathways involved in demyelination.
Methods Used
- Transgenic ODC-OVA mice were used to study oligodendrocyte responses.
- Brain sections were prepared using a vibratome and cultured in appropriate media.
- Activated CD8+ T cells were introduced to the brain slices to observe interactions.
- Cell death was assessed post-incubation using histological techniques.
Main Results
- Activated CD8+ T cells effectively induced apoptosis in oligodendrocytes.
- Signaling pathways involving perforin and granzymes were activated during T cell-oligodendrocyte interactions.
- Fas ligand binding contributed to the apoptotic process in oligodendrocytes.
- The methodology allowed for precise observation of cell death mechanisms in vitro.
Conclusions
- The study highlights the critical role of T cells in demyelination and neuronal death.
- Understanding these interactions may lead to new therapeutic approaches for neurodegenerative diseases.
- Future research should focus on targeting these pathways to protect oligodendrocytes and preserve myelin.
Frequently Asked Questions
Executive Industry Relevance
This ex vivo model enables precise interrogation of immune-mediated neuronal death mechanisms relevant to demyelinating disorders. By isolating oligodendrocyte-specific CD8+ T cell interactions in brain slices, the technique supports mechanistic de-risking and target validation for neuroinflammatory disease pipelines. The approach provides actionable insights for early-stage portfolio triage and translational continuity in neuroimmunology R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct testing of immune cell-mediated cytotoxicity against oligodendrocytes.
- Clarifies the mechanistic link between demyelination and neuronal death in a controlled system.
- Supports functional validation of immune targets implicated in neurodegeneration.
- Facilitates predictive confidence in pathway selection for neuroinflammatory indications.
Screening & Assay Development
- Provides a reproducible ex vivo platform for evaluating immune cell effects on CNS tissue.
- Allows quantitative assessment of neuronal and myelin damage post T cell exposure.
- Supports standardization of immune-mediated cytotoxicity assays for compound screening.
- Enables scalability for comparative studies across immune cell populations or interventions.
Translational & Preclinical Research
- Aligns with disease-relevant mechanisms observed in demyelinating CNS disorders.
- Bridges discovery findings to preclinical validation of immune-modulating strategies.
- Informs biomarker development by linking immune activity to histological outcomes.
- De-risks advancement of immunotherapeutic candidates targeting CNS inflammation.
Pipeline & Workflow Integration
This ex vivo assay fits at the interface of early discovery and preclinical validation, enabling mechanistic studies before in vivo modeling or lead optimization.
- Discovery Biology: Supports hypothesis testing on immune-mediated oligodendrocyte injury and neuronal loss.
- Screening: Delivers quantitative, reproducible readouts of cell death and demyelination for candidate evaluation.
- Analytics: Provides histological and cell-counting outputs to compare immune cell effects across conditions.
- Translational Research: Connects immune mechanisms to disease-relevant tissue pathology, informing biomarker strategies.
- Enterprise Reuse: Offers a modular platform adaptable to various immune cell types or CNS targets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune target validation and mechanistic de-risking.
- Operational Value: Standardizes immune-mediated cytotoxicity assessment in CNS tissue models.
- Strategic Value: Enables informed go/no-go decisions for neuroinflammatory and demyelinating disease programs.
- Portfolio Impact: Supports risk-adjusted prioritization of immunomodulatory assets targeting CNS pathology.
Implementation Considerations
- Requires expertise in neuroimmunology and ex vivo brain slice preparation.
- Needs access to vibratome instrumentation and histological analysis infrastructure.
- Demands cross-team standardization for cell preparation and quantitative assessment.
- Adaptable to different transgenic models or immune cell specificities as needed.
- Limited to acute ex vivo timeframes and may not capture chronic disease dynamics.
Biopharma FAQs
Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
Related Videos
0 Views
Robust and Highly Reproducible Generation of Cortical Brain Organoids for Modelling Brain Neuronal Senescence In Vitro
Related Videos
0 Views
Organotypic Cultures of Adult Human Cortex as an Ex vivo Model for Human Stem Cell Transplantation and Validation
Related Videos
0 Views
Antigen Specific In Vivo Killing Assay using CFSE Labeled Target Cells
Related Videos
0 Views
Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depolarization
Related Videos
0 Views
Neuronal Death Assay to Evaluate Cell Death in Ex Vivo Epilepsy Model
Related Videos
0 Views
An Immunological Technique to Monitor Adjuvant-Mediated Cytotoxic T Lymphocyte Generation
Related Videos
0 Views
An In Vitro Transduction-Induced Myelination Assay for Oligodendrocyte Precursor Cells
Related Videos
0 Views
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Related Videos
0 Views
Rapid and Specific Immunomagnetic Isolation of Mouse Primary Oligodendrocytes
Related Videos
0 Views
Last updated: 22 August 2026